BackgroundCheck.run
Search For

Sam H Lee, 65Boise, ID

Known as:
Sam Hoi Lee Su H Lee
Related to:
Shiu Lee 100 Joy Lee S Lee Christina Lee 43 Sa Lee

Sam Lee Phones & Addresses

Boise, ID   

Renton, WA   

Federal Way, WA   

Work

Company: R.j. reynolds tobacco company - Los Angeles, CA 2007 Position: Senior manager - division trade marketing

Education

School / High School: EASTERN WASHINGTON UNIVERSITY- Cheney, WA Mar 2001 Specialities: Bachelor of Arts in Marketing
Get Report
Control this profile

Mentions for Sam H Lee

Career records & work history

Medicine Doctors

Sam M. Lee

Specialties:
Pediatric Cardiology
Work:
VCU Childrens Pavillion
1001 E Marshall St FL 4, Richmond, VA 23298
804-6287337 (phone) 804-8288517 (fax)
Education:
Medical School
Medical College of Georgia School of Medicine
Graduated: 1998
Procedures:
Cardiac Stress Test, Continuous EKG, Echocardiogram, Electrocardiogram (EKG or ECG), Pulmonary Function Tests
Conditions:
Aortic Regurgitation, Aortic Stenosis, Atrial Fibrillation and Atrial Flutter, Bacterial Pneumonia, Cardiac Arrhythmia, Cardiomyopathy, Conduction Disorders, Congenital Anomalies of the Heart, Diabetes Mellitus (DM), Heart Failure, Hypertension (HTN), Mitral Regurgitation, Overweight and Obesity, Paroxysmal Supreventricular Tachycardia (PSVT), Pericardidtis, Sickle-Cell Disease, Skin and Subcutaneous Infections, Valvular Heart Disease
Languages:
English
Description:
Dr. Lee graduated from the Medical College of Georgia School of Medicine in 1998. He works in Richmond, VA and specializes in Pediatric Cardiology. Dr. Lee is affiliated with Virginia Commonwealth University Medical Center.

Sam Lee

Specialties:
Surgery , Neurological
Work:
Washington Medical GroupWashington Township Medical Foundation
2500 Mowry Ave STE 222, Fremont, CA 94538
510-8181160 (phone) 510-8181195 (fax)
Site
Languages:
English
Description:
Mr. Lee works in Fremont, CA and specializes in Surgery , Neurological. Mr. Lee is affiliated with Washington Hospital.
Sam Lee Photo 1

Sam Min Lee

Specialties:
Psychiatry

License Records

Sam Chandler Lee Taxis

Licenses:
License #: 0402035258
Category: Professional Engineer License

Sam Lee resumes & CV records

Resumes

Sam Lee Photo 42

Sam Lee - Renton, WA

Work:
R.J. REYNOLDS TOBACCO COMPANY - Los Angeles, CA 2007 to 2010
Senior Manager - Division Trade Marketing R.J. REYNOLDS TOBACCO COMPANY - Albuquerque, NM 2006 to 2007
Retail Manager R.J. REYNOLDS TOBACCO COMPANY - Shreveport, LA 2005 to 2006
Account Manager R.J. REYNOLDS TOBACCO COMPANY - Seattle, WA 2001 to 2005
Trade Marketing Representative
Education:
EASTERN WASHINGTON UNIVERSITY - Cheney, WA Mar 2001
Bachelor of Arts in Marketing WASHINGTON STATE UNIVERSITY - Pullman, WA
Marketing

Publications & IP owners

Us Patents

Inhibitors Of Hepatitis C Virus Polymerase

US Patent:
2012018, Jul 19, 2012
Filed:
Dec 16, 2011
Appl. No.:
13/328036
Inventors:
Sam SK Lee - Lynnwood WA, US
Wang Shen - San Mateo CA, US
Xiaoling Zheng - Fremont CA, US
Irina C. Jacobson - Sammamish WA, US
Assignee:
COCRYSTAL DISCOVERY, INC. - Bothell WA
International Classification:
A61K 31/4436
C07D 487/04
A61K 31/519
C07D 417/14
C07D 409/14
A61K 31/444
A61K 31/497
C07D 413/14
C07D 498/04
C07D 471/04
A61K 31/4709
A61K 38/21
A61K 31/7056
A61P 31/14
A61K 31/4439
C07D 409/04
US Classification:
424 854, 5462804, 514336, 544281, 5142593, 546256, 514333, 544405, 51425505, 544263, 51425931, 546115, 514302, 546118, 514303, 546176, 514314, 514 43, 5462697, 514342, 5462754, 514341, 5462714, 514340, 5462721, 5462747, 5462774, 514339, 5462757, 546119
Abstract:
The present invention provides, among other things, compounds represented by the general Formula I:and pharmaceutically acceptable salts thereof, wherein X, Y, R, R, R, and Rare as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.

Use Of Dd1Alpha (Vista) Modulators In Cancer Treatment: Immunotherapy Based On The Disruption Of Dd1Alpha/Pd-1 Signaling

US Patent:
2022040, Dec 22, 2022
Filed:
Jun 16, 2022
Appl. No.:
17/842235
Inventors:
Sam LEE - Bellevue WA, US
International Classification:
A61K 39/00
Abstract:
Provided herein are compositions and methods for treating immune diseases or disorders, including cancer. In some embodiments, the compositions and methods are directed to the use of anti-DD1α antibodies to modulate the immune-regulatory activity of DD1α, thereby promoting anti-tumor immunity. Methods for identifying patients that are likely to respond to anti-DD1α therapy, and for treating such patients with anti-DD1α antibody compositions are also provided.

Formulations Of Influenza Therapeutics

US Patent:
2021039, Dec 23, 2021
Filed:
Nov 13, 2019
Appl. No.:
17/292863
Inventors:
- Bothell WA, US
Liang Mao - Shanghai, CN
Irina C. Jacobson - Sammamish WA, US
Sam SK Lee - Edmonds WA, US
International Classification:
A61K 31/506
A61K 9/00
A61K 9/16
Abstract:
Provided herein are compositions of an antiviral therapeutic to treat influenza suitable for administration via inhalation.

Combinations Of Inhibitors Of Influenza Virus Replication

US Patent:
2021035, Nov 18, 2021
Filed:
Oct 17, 2019
Appl. No.:
17/286026
Inventors:
- Bothell WA, US
Biing Yuan Lin - Bellevue WA, US
Sam SK Lee - Edmonds WA, US
International Classification:
A61K 31/519
A61K 39/145
A61K 45/06
Abstract:
Provided herein are combinations of compounds that can inhibit the replication of influenza viruses, reduce the amount of influenza viruses, and/or treat influenza.

Combination Therapy For Treatment Of Hcv

US Patent:
2021016, Jun 3, 2021
Filed:
May 9, 2019
Appl. No.:
17/047209
Inventors:
- Bothell WA, US
Biing Yuan Lin - Bellevue WA, US
Sam SK Lee - Edmonds WA, US
International Classification:
A61K 31/7072
A61K 31/4439
A61K 31/498
A61K 31/4188
A61P 31/14
Abstract:
Disclosed herein are combination therapies for use in the treatment or prevention of HCV by administering Compound A and a second HCV inhibitor.

Pyrrolo[2,3-B]Pyridin Derivatives As Inhibitors Of Influenza Virus Replication

US Patent:
2021012, Apr 29, 2021
Filed:
Jul 26, 2019
Appl. No.:
17/259397
Inventors:
- Bothell WA, US
Sam SK Lee - Edmonds WA, US
Michael David Feese - Seattle WA, US
International Classification:
A61K 31/506
A61K 45/06
A61K 39/145
C07D 471/04
A61P 31/16
Abstract:
Provided herein are compounds of Formula A, B or C that can inhibit the replication of influenza viruses, reduce the amount of influenza viruses, and/or treat influenza.

Inhibitors Of Hepatitis C Virus Polymerase

US Patent:
2020025, Aug 13, 2020
Filed:
Sep 25, 2019
Appl. No.:
16/582468
Inventors:
- Bothell WA, US
Michael D. Feese - Seattle WA, US
Sam S.K. Lee - Edmonds WA, US
International Classification:
C07D 307/84
A61K 31/343
A61K 45/06
Abstract:
The present invention provides, among other things, compounds represented by the general Formula I: (I) and pharmaceutically acceptable salts thereof, wherein L and A (and further substituents) are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.

Pyrrolopyrimidine Derivatives Useful As Inhibitors Of Influenza Virus Replication

US Patent:
2020012, Apr 23, 2020
Filed:
Apr 24, 2018
Appl. No.:
16/603951
Inventors:
- Bothell WA, US
Michael David Feese - Seattle WA, US
Sam SK Lee - Edmonds WA, US
International Classification:
C07D 519/00
A61K 9/00
A61K 9/127
A61K 9/14
A61P 31/16
Abstract:
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient a safe and effective amount of a compound represented by any of Formulas I-III, or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a safe and effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

Isbn (Books And Publications)

Cinturon Negro

Author:
Sam Lee
ISBN #:
8484030660

Grandes Mitos De Las Artes Marciales

Author:
Sam Lee
ISBN #:
8484030873

Ninja Ii

Author:
Sam Lee
ISBN #:
8484031101

Tae-Kwon-Do

Author:
Sam Lee
ISBN #:
8484033295

Possible Relatives

Cynthia C Lee  Davis Lee  Dawn P Lee  Dean M Lee  Dae S Lee  Deanna L Lee  Daina M Lee  Sam Jones  Sam Starr  Sam Whitfield 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.